Illumina CEO 'Optimistic' about Array Business as Q1 Sales Spike 47 Percent

The "continued success" of its next-generation sequencing instruments and "strong results" in its array business helped the company report a 47-percent increase in first-quarter sales.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.